Table 2 Neural crest genes compiled using Phenotype Ontology annotations (phenotypic information derived from mutant mice studies)
From: New genes in the evolution of the neural crest differentiation program
| Group | Gene |
|---|---|
| Deuterostomia | Brain derived neurotrophic factor |
| Fanconi anemia, complementation group A | |
| Fos-like antigen 2 | |
| Neurotropin 3 | |
| Noggin | |
| Purinergic receptor P2X, ligand-gated ion channel, 7 | |
| Rod outer segment membrane protein 1 | |
| Vertebrata | BCL2-like 11 (apoptosis facilitator) |
| Calcitonin/calcitonin-related polypeptide, alpha | |
| Cocaine and amphetamine regulated transcript | |
| Endothelin 1 | |
| Endothelin 3 | |
| Formin 1 | |
| Glial cell line derived neurotrophic factor | |
| Gonadotropin releasing hormone 1 | |
| Hermansky-Pudlak syndrome 6 | |
| Integrin, alpha 10 | |
| Islet amyloid polypeptide | |
| Leukocyte cell derived chemotaxin 1 | |
| Matrix Gla protein | |
| Melanoma inhibitory activity 1 | |
| Myelin protein zero | |
| Natriuretic peptide precursor type C | |
| Neuregulin 1 | |
| Neurturin | |
| Parathyroid hormone | |
| Parathyroid hormone-like peptide | |
| Phosphodiesterase 6G, cGMP-specific, rod, gamma | |
| Pro-opiomelanocortin-alpha | |
| Silver | |
| Tenomodulin | |
| Treacher Collins Franceschetti syndrome 1, homolog | |
| Chordata | Activating transcription factor 4 |
| Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | |
| Claudin 14 | |
| Epilepsy, progressive myoclonic epilepsy, type 2 gene alpha | |
| Fos-like antigen 1 | |
| Gap junction membrane channel protein beta 6 | |
| Hyaluronan and proteoglycan link protein 1 | |
| Transforming growth factor, beta receptor III | |
| Mammalia | Adrenocortical dysplasia |
| Ameloblastin | |
| Amelogenin X chromosome | |
| BH3 interacting domain death agonist | |
| Colony stimulating factor 2 (granulocyte-macrophage) | |
| Harakiri, BCL2 interacting protein (contains only BH3 domain) | |
| Kit ligand | |
| Leptin | |
| Matrix extracellular phosphoglycoprotein with ASARM motif (bone) | |
| MyoD family inhibitor | |
| Nonagouti | |
| Oncostatin M | |
| Programmed cell death 1 | |
| TYRO protein tyrosine kinase binding protein |
